Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19
about
Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K.A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells.Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity.Agammaglobulinemia: causative mutations and their implications for novel therapies.Mutations in Bruton's tyrosine kinase impair IgA responses.
P2860
Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19
@ast
Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19
@en
type
label
Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19
@ast
Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19
@en
prefLabel
Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19
@ast
Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19
@en
P2093
P2860
P1433
P1476
Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19
@en
P2093
Amma Bosompem
Elaine Coustan-Smith
Frank T Saulsbury
Gayle Tyerman
Mary Ellen Conley
P2860
P304
P356
10.1182/BLOOD-2011-01-330472
P407
P50
P577
2011-06-21T00:00:00Z